McGill University undergrad Daniel Miksha made a significant decision over the weekend. After hearing the news that U.S.
China is quick to act when US tariffs on its imports go into effect, but experts say it’s leaving room for negotiation.
The UK has been "out of line" but the situation "can be worked out", Trump said, adding that he has been "getting along very well" with UK Prime Minister Sir Keir Starmer. This comes as Starmer heads ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...